USPTO TTABVUE. Trademark Trial and Appeal Board Inquiry System

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

TTABVUE. Trademark Trial and Appeal Board Inquiry System

v2.5.0

Summary

Query: Party Name contains all words: SB PHARMCO PUERTO RICO INC.
Number of results: 27
Results are in reverse chronological order

Proceeding
Filing Date

Defendant(s),
Property(ies)

Plaintiff(s),
Property(ies)

77503739
12/02/2008

SB Pharmco Puerto Rico Inc.
S#:77503739

Celgene Corporation

77452565
11/26/2008

KCI Licensing, Inc.
S#:77452565

SmithKline Beecham (Cork) Limited
SB Pharmco Puerto Rico, Inc.

78862010
08/01/2007

SHIRE LLC
Mark: MESAVANTZ S#:78862010

SB Pharmco Puerto Rico Inc.

78861775
08/01/2007

SHIRE LLC
Mark: MESAVANT S#:78861775

SB Pharmco Puerto Rico Inc.

78660976
10/14/2005

Alcon, Inc.
Mark: AVANTERA S#:78660976

SB Pharmco Puerto Rico Inc.

78660980
10/05/2005

Alcon, Inc.
Mark: AVANTRA S#:78660980

SB Pharmco Puerto Rico Inc.
Solvay Pharmaceuticals B.V.

78527821
10/03/2005

SB Pharmco Puerto Rico Inc.
Mark: AVANDEGE S#:78527821

Allergan, Inc.

78527747
10/03/2005

SB Pharmco Puerto Rico Inc.
Mark: AVANDAGE S#:78527747

Allergan, Inc.

78527792
10/03/2005

SB Pharmco Puerto Rico Inc.
Mark: AVANEGE S#:78527792

Allergan, Inc.

78527718
10/03/2005

SB Pharmco Puerto Rico Inc.
Mark: AVANAGE S#:78527718

Allergan, Inc.

78412914
03/15/2005

SB Pharmco Puerto Rico Inc.
Mark: PPARPAN: COMPREHENSIVE METABOLIC THERAPY S#:78412914

Eli Lilly and Company

78412894
03/15/2005

SB Pharmco Puerto Rico Inc.
Mark: PPARPAN: THE TRIPLE AGONIST FOR METABOLIC THERAPY S#:78412894

Eli Lilly and Comapny

78412870
03/15/2005

SB Pharmco Puerto Rico Inc.
Mark: PPARPAN: NEW DIRECTIONS IN METABOLIC THERAPY S#:78412870

Eli Lilly and Company

78412852
03/15/2005

SB Pharmco Puerto Rico Inc.
Mark: PPARPAN: INNOVATION IN METABOLIC THERAPY S#:78412852

Eli Lilly and Company

78412885
03/15/2005

SB Pharmco Puerto Rico Inc.
Mark: PPARPAN: NEXT GENERATION METABOLIC THERAPY S#:78412885

Eli Lilly and Company

91163093
11/22/2004

Adams, Christopher, Peter
Mark: PRANDIA S#:78295191

SB Pharmco Puerto Rico Inc.

78295191
10/11/2004

Adams, Christopher, Peter
Mark: PRANDIA S#:78295191

SB Pharmco Puerto Rico Inc.
Novo Nordisk A/S
Mark: PRANDIN S#:75272035 R#:2330531

78340390
09/28/2004

SUCAMPO PHARMACEUTICALS, INC.
Mark: AVANILE S#:78340390

Sanofi-Synthelabo
SB Pharmco Puerto Rico Inc.

78227823
07/23/2004

SB Pharmco Puerto Rico Inc.
Mark: PPARPAN S#:78227823

Eli Lilly and Company

78227819
06/01/2004

SB Pharmco Puerto Rico Inc.
Mark: PPARPAN S#:78227819

Eli Lilly and Company

78143889
04/16/2003

SB Pharmco Puerto Rico, Inc.
Mark: DURABLE POWER OF TWO S#:78143889

Johnson & Johnson

76343638
02/12/2003

Rath, Matthias
Mark: METAVIT S#:76343638

SB PHARMCO PUERTO RICO, INC. GLAXOSMITHKLINE COPORATE INTELLECTUAL PROPERTY-TM(UW2221

91154532
01/08/2003

SB Pharmco Puerto Rico Inc.
Mark: SURVANDIA S#:78114475

Abbott Laboratories

78064377
12/30/2002

SB Pharmco Puerto Rico Inc.
Mark: AVANTIX S#:78064377

Bayer Aktiengesellschaft
Aventis

78130108
12/20/2002

Pharmacia & Upjohn Company
Mark: AVANCOR S#:78130108

SB Pharmco Puerto Rico, Inc.
KOS PHARMACEUTICALS, INC.